Compare, Analyse Fulford India with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs ACTAVIS (US) - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FULFORD INDIA   ACTAVIS
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
ACTAVIS
Dec-18
FULFORD INDIA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs94213,998-   
Low Rs4509,390-   
Sales per share (Unadj.) Rs691.43,433.6-  
Earnings per share (Unadj.) Rs11.5-1,106.0-  
Cash flow per share (Unadj.) Rs15.4361.8-  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.30-  
Book value per share (Unadj.) Rs380.014,162.2-  
Shares outstanding (eoy) m3.90332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.4 29.6%   
Avg P/E ratio x60.7-10.6 -574.3%  
P/CF ratio (eoy) x45.332.3 140.2%  
Price / Book Value ratio x1.80.8 221.8%  
Dividend payout %17.40-   
Avg Mkt Cap Rs m2,7143,889,345 0.1%   
No. of employees `0000.416.9 2.6%   
Total wages/salary Rs m5050-   
Avg. sales/employee Rs Th6,073.067,575.8 9.0%   
Avg. wages/employee Rs Th1,137.40-   
Avg. net profit/employee Rs Th100.7-21,766.2 -0.5%   
INCOME DATA
Net Sales Rs m2,6961,142,032 0.2%  
Other income Rs m12521,839 0.6%   
Total revenues Rs m2,8221,163,871 0.2%   
Gross profit Rs m-4629,927 -0.2%  
Depreciation Rs m15488,194 0.0%   
Interest Rs m1065,902 0.0%   
Profit before tax Rs m54-502,329 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0128,114 0.0%   
Tax Rs m10-6,366 -0.2%   
Profit after tax Rs m45-367,849 -0.0%  
Gross profit margin %-1.72.6 -65.7%  
Effective tax rate %17.71.3 1,395.1%   
Net profit margin %1.7-32.2 -5.1%  
BALANCE SHEET DATA
Current assets Rs m1,738468,402 0.4%   
Current liabilities Rs m545414,364 0.1%   
Net working cap to sales %44.34.7 935.5%  
Current ratio x3.21.1 282.3%  
Inventory Days Days4820 247.5%  
Debtors Days Days466 6.5%  
Net fixed assets Rs m12129,272 0.0%   
Share capital Rs m390-   
"Free" reserves Rs m1,4430-   
Net worth Rs m1,4824,710,347 0.0%   
Long term debt Rs m01,658,684 0.0%   
Total assets Rs m2,0777,363,344 0.0%  
Interest coverage x6.7-6.6 -101.4%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.30.2 837.2%   
Return on assets %2.6-4.1 -63.6%  
Return on equity %3.0-7.8 -38.6%  
Return on capital %4.3-4.8 -88.9%  
Exports to sales %00-   
Imports to sales %24.50-   
Net fx Rs m-6560-   
CASH FLOW
From Operations Rs m90408,005 0.0%  
From Investments Rs m105224,145 0.0%  
From Financial Activity Rs m-14-700,258 0.0%  
Net Cashflow Rs m181-67,768 -0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 72.34 Rs / USD

Compare FULFORD INDIA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare FULFORD INDIA With: GSK PHARMA  CIPLA  SUN PHARMA  ALKEM LABORATORIES  ELDER PHARMA  



Today's Market

Upcoming IPOs, NTPC-GAIL Share Purchase Agreement, and Buzzing Stocks Today(Pre-Open)

Indian share markets witnessed huge buying interest during the extended closing hours yesterday and ended on a strong note.

Related Views On News

Most Popular

Intraday Trading for a Living (Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Penny Stock Master Series: The Quest for 10X Profits in 10 Years (Profit Hunter)

Feb 12, 2021

This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Access Now: Eight Steps to Your Eight Figure Fortune
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON FULFORD INDIA

FULFORD INDIA - LUPIN COMPARISON

COMPARE FULFORD INDIA WITH

FEATURED VIDEOS

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

Nasdaq & Nifty Could Reverse

Don't Fall for the 'Best Sector of 2021' Story

More Featured Videos

MARKET STATS